Published December 3, 2024 | Version v1

Mortality of ST-Elevation Myocardial Infarction (STEMI) in Mexico: Current Trends, Challenges, and Strategies for Improvement

  • 1. Tecnológico de Monterrey Campus Monterrey, Nuevo Léon, Mexico
  • 2. Universidad Cuauhtémoc Plantel Aguascalientes. Aguascalientes, México.
  • 3. Universidad Autónoma de Aguascalientes. Aguascalientes, Mexico.
  • 4. Universidad Autonoma de Guadalajara. Zapopan, Jalisco, México.

Description

ST-Elevation Myocardial Infarction (STEMI) remains a leading cause of cardiovascular mortality worldwide, with significant regional disparities. In Mexico, despite advances in healthcare systems and the availability of reperfusion therapies, STEMI continues to contribute substantially to cardiovascular-related deaths. This article reviews the mortality rates associated with STEMI in Mexico, focusing on epidemiological trends, barriers to optimal care, and regional healthcare inequalities. Key factors influencing outcomes include delayed diagnosis, limited access to percutaneous coronary intervention (PCI), socioeconomic determinants, and regional variability in healthcare infrastructure. Strategies to mitigate these challenges, such as strengthening prehospital care, expanding reperfusion networks, and addressing healthcare inequities, are discussed. This review underscores the urgent need for nationwide efforts to optimize STEMI management and reduce associated mortality.

Files

1988-Article Text-5085-1-10-20241203.pdf

Files (458.9 kB)

Name Size Download all
md5:57932a4dabd83ecf1203d2b9296f139e
458.9 kB Preview Download